Cullinan Therapeutics Inc (CGEM)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
CAMBRIDGE, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...
CAMBRIDGE, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...
Preliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically unresponsive to pembrolizumab, such as...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.38 | 7.44738262277 | 18.53 | 21.01 | 18.04 | 806331 | 19.6063537 | CS |
| 4 | 3.37 | 20.3748488513 | 16.54 | 21.01 | 15.67 | 720732 | 17.95560926 | CS |
| 12 | -8.31 | -29.447200567 | 28.22 | 30.1886 | 15.57 | 815867 | 21.10589007 | CS |
| 26 | 7.23 | 57.0189274448 | 12.68 | 30.1886 | 12.46 | 741344 | 20.17980389 | CS |
| 52 | 9.62 | 93.4888241011 | 10.29 | 30.1886 | 7.64 | 463678 | 17.97333986 | CS |
| 156 | -5.99 | -23.1274131274 | 25.9 | 30.325 | 7.3 | 333772 | 15.73558232 | CS |
| 260 | -22.09 | -52.5952380952 | 42 | 59.85 | 7.3 | 323597 | 18.26400219 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
